• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析美国国立卫生研究院小分子文库中在还原环境下通过氧化还原循环产生过氧化氢的化合物。

Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.

作者信息

Soares Karina M, Blackmon Nicole, Shun Tong Ying, Shinde Sunita N, Takyi Harold K, Wipf Peter, Lazo John S, Johnston Paul A

机构信息

Pittsburgh Molecular Library Screening Center, Drug Discovery Institute, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.

出版信息

Assay Drug Dev Technol. 2010 Apr;8(2):152-74. doi: 10.1089/adt.2009.0247.

DOI:10.1089/adt.2009.0247
PMID:20070233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3098569/
Abstract

We have screened the Library of Pharmacologically Active Compounds (LOPAC) and the National Institutes of Health (NIH) Small Molecule Repository (SMR) libraries in a horseradish peroxidase-phenol red (HRP-PR) H2O2 detection assay to identify redox cycling compounds (RCCs) capable of generating H2O2 in buffers containing dithiothreitol (DTT). Two RCCs were identified in the LOPAC set, the ortho-naphthoquinone beta-lapachone and the para-naphthoquinone NSC 95397. Thirty-seven (0.02%) concentration-dependent RCCs were identified from 195,826 compounds in the NIH SMR library; 3 singleton structures, 9 ortho-quinones, 2 para-quinones, 4 pyrimidotriazinediones, 15 arylsulfonamides, 2 nitrothiophene-2-carboxylates, and 2 tolyl hydrazides. Sixty percent of the ortho-quinones and 80% of the pyrimidotriazinediones in the library were confirmed as RCCs. In contrast, only 3.9% of the para-quinones were confirmed as RCCs. Fifteen of the 251 arylsulfonamides in the library were confirmed as RCCs, and since we screened 17,868 compounds with a sulfonamide functional group we conclude that the redox cycling activity of the arylsulfonamide RCCs is due to peripheral reactive enone, aromatic, or heterocyclic functions. Cross-target queries of the University of Pittsburgh Drug Discovery Institute (UPDDI) and PubChem databases revealed that the RCCs exhibited promiscuous bioactivity profiles and have populated both screening databases with significantly higher numbers of active flags than non-RCCs. RCCs were promiscuously active against protein targets known to be susceptible to oxidation, but were also active in cell growth inhibition assays, and against other targets thought to be insensitive to oxidation. Profiling compound libraries or the hits from screening campaigns in the HRP-PR H(2)O(2) detection assay significantly reduce the timelines and resources required to identify and eliminate promiscuous nuisance RCCs from the candidates for lead optimization.

摘要

我们在辣根过氧化物酶-酚红(HRP-PR)H₂O₂检测试验中,对药理活性化合物库(LOPAC)和美国国立卫生研究院(NIH)小分子储存库(SMR)进行了筛选,以鉴定能够在含有二硫苏糖醇(DTT)的缓冲液中产生H₂O₂的氧化还原循环化合物(RCC)。在LOPAC库中鉴定出两种RCC,即邻萘醌β-拉帕醌和对萘醌NSC 95397。从NIH SMR库中的195,826种化合物中鉴定出37种(0.02%)浓度依赖性RCC;3种单结构、9种邻醌、2种对醌、4种嘧啶并三嗪二酮、15种芳基磺酰胺、2种硝基噻吩-2-羧酸盐和2种甲苯酰肼。库中60%的邻醌和80%的嘧啶并三嗪二酮被确认为RCC。相比之下,只有3.9%的对醌被确认为RCC。库中251种芳基磺酰胺中的15种被确认为RCC,并且由于我们筛选了17,868种具有磺酰胺官能团的化合物,我们得出结论,芳基磺酰胺RCC的氧化还原循环活性归因于外围反应性烯酮、芳香族或杂环官能团。匹兹堡大学药物发现研究所(UPDDI)和PubChem数据库的交叉目标查询显示,RCC表现出混杂的生物活性谱,并且与非RCC相比,在两个筛选数据库中具有显著更多的活性标记。RCC对已知易受氧化影响的蛋白质靶标具有混杂活性,但在细胞生长抑制试验中也具有活性,并且对其他被认为对氧化不敏感的靶标也有活性。在HRP-PR H₂O₂检测试验中对化合物库或筛选活动的命中物进行分析,可显著缩短从潜在药物优化候选物中鉴定和消除混杂的有害RCC所需的时间和资源。

相似文献

1
Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.分析美国国立卫生研究院小分子文库中在还原环境下通过氧化还原循环产生过氧化氢的化合物。
Assay Drug Dev Technol. 2010 Apr;8(2):152-74. doi: 10.1089/adt.2009.0247.
2
Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents.开发一种384孔比色测定法,用于在还原剂存在下定量由化合物的氧化还原循环产生的过氧化氢。
Assay Drug Dev Technol. 2008 Aug;6(4):505-18. doi: 10.1089/adt.2008.151.
3
Redox cycling compounds generate H2O2 in HTS buffers containing strong reducing reagents--real hits or promiscuous artifacts?氧化还原循环化合物在含有强还原剂的 HTS 缓冲液中生成 H2O2——是真正的命中物还是混杂的假象?
Curr Opin Chem Biol. 2011 Feb;15(1):174-82. doi: 10.1016/j.cbpa.2010.10.022. Epub 2010 Nov 11.
4
Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.在国立卫生研究院化合物库的高通量筛选中鉴定出的Cdc25B双特异性磷酸酶抑制剂。
Assay Drug Dev Technol. 2009 Jun;7(3):250-65. doi: 10.1089/adt.2008.186.
5
Utility of Resazurin, Horseradish Peroxidase, and NMR Assays to Identify Redox-Related False-Positive Behavior in High-Throughput Screens.刃天青、辣根过氧化物酶和核磁共振分析在高通量筛选中识别氧化还原相关假阳性行为的效用。
Assay Drug Dev Technol. 2018 Apr;16(3):171-191. doi: 10.1089/adt.2017.838. Epub 2018 Apr 2.
6
Coupled oxidation of aromatic hydrocarbons by horseradish peroxidase and hydrogen peroxide.辣根过氧化物酶和过氧化氢对芳香烃的偶联氧化作用。
Chemosphere. 2003 Jan;50(1):105-9. doi: 10.1016/s0045-6535(02)00488-5.
7
High-throughput identification of promiscuous inhibitors from screening libraries with the use of a thiol-containing fluorescent probe.利用含硫醇的荧光探针从筛选文库中高通量鉴定混杂抑制剂。
J Biomol Screen. 2013 Jul;18(6):705-13. doi: 10.1177/1087057113476090. Epub 2013 Feb 27.
8
Phenol derivatives as enhancers and inhibitors of luminol-H2O2-horseradish peroxidase chemiluminescence.作为鲁米诺-H2O2-辣根过氧化物酶化学发光增强剂和抑制剂的酚类衍生物
J Biolumin Chemilumin. 1998 Mar-Apr;13(2):75-84. doi: 10.1002/(SICI)1099-1271(199803/04)13:2<75::AID-BIO469>3.0.CO;2-7.
9
Large-scale bioactivity analysis of the small-molecule assayed proteome.小分子检测蛋白质组的大规模生物活性分析。
PLoS One. 2017 Feb 8;12(2):e0171413. doi: 10.1371/journal.pone.0171413. eCollection 2017.
10
Characterisation of a haem active-site mutant of horseradish peroxidase, Phe41----Val, with altered reactivity towards hydrogen peroxide and reducing substrates.辣根过氧化物酶血红素活性位点突变体Phe41→Val对过氧化氢和还原底物反应性改变的表征
Eur J Biochem. 1992 Jul 15;207(2):507-19. doi: 10.1111/j.1432-1033.1992.tb17077.x.

引用本文的文献

1
Biochemical evaluation of novel thiazolone derivatives as dual α-glucosidase/α-amylase inhibitors, anti-inflammatory agents.新型噻唑啉酮衍生物作为双功能α-葡萄糖苷酶/α-淀粉酶抑制剂及抗炎剂的生化评价
Future Med Chem. 2025 Jan;17(2):209-219. doi: 10.1080/17568919.2024.2447225. Epub 2024 Dec 29.
2
Discovery of PL and M Inhibitors for SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的PL和M抑制剂的发现。
ACS Omega. 2023 Jun 14;8(25):22603-22612. doi: 10.1021/acsomega.3c01110. eCollection 2023 Jun 27.
3
Reference compounds for characterizing cellular injury in high-content cellular morphology assays.用于鉴定高通量细胞形态学分析中细胞损伤的参考化合物。
Nat Commun. 2023 Mar 13;14(1):1364. doi: 10.1038/s41467-023-36829-x.
4
Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities.新型1,3,5-三取代-2-硫代咪唑烷-4-酮类似物的抗糖尿病潜力:对α-葡萄糖苷酶、α-淀粉酶及抗氧化活性的深入研究
Pharmaceuticals (Basel). 2022 Dec 17;15(12):1576. doi: 10.3390/ph15121576.
5
Optimization of an Protocol Using Probe Permeabilities to Identify Membrane Pan-Assay Interference Compounds.优化探针渗透率协议,以识别膜泛分析干扰化合物。
J Chem Inf Model. 2022 Jun 27;62(12):3034-3042. doi: 10.1021/acs.jcim.2c00372. Epub 2022 Jun 13.
6
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.靶向 SARS-CoV-2 木瓜蛋白酶样蛋白酶的进展与挑战。
J Med Chem. 2022 Jun 9;65(11):7561-7580. doi: 10.1021/acs.jmedchem.2c00303. Epub 2022 May 27.
7
Exponential amplification by redox cross-catalysis and unmasking of doubly protected molecular probes.通过氧化还原交叉催化实现指数级放大以及双重保护分子探针的去掩蔽
Chem Sci. 2022 Feb 11;13(9):2764-2777. doi: 10.1039/d1sc06086d. eCollection 2022 Mar 2.
8
Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.无实际痛苦的收获:“公平试验策略”在多靶点配体开发中的地位。
Acta Pharm Sin B. 2021 Nov;11(11):3417-3432. doi: 10.1016/j.apsb.2021.02.023. Epub 2021 Mar 4.
9
The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL In Vitro.重新利用的药物苏拉明和奎纳克林在体外协同抑制新型冠状病毒3CL蛋白酶
Viruses. 2021 May 10;13(5):873. doi: 10.3390/v13050873.
10
Towards reproducible computational drug discovery.迈向可重复的计算药物发现。
J Cheminform. 2020 Jan 28;12(1):9. doi: 10.1186/s13321-020-0408-x.

本文引用的文献

1
Literature search and review.文献检索与综述。
Assay Drug Dev Technol. 2011 Jun;9(3):198-212. doi: 10.1089/adt.2011.0903.lr.
2
Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.在国立卫生研究院化合物库的高通量筛选中鉴定出的Cdc25B双特异性磷酸酶抑制剂。
Assay Drug Dev Technol. 2009 Jun;7(3):250-65. doi: 10.1089/adt.2008.186.
3
An AlphaScreen-based high-throughput screen to identify inhibitors of Hsp90-cochaperone interaction.一种基于AlphaScreen的高通量筛选方法,用于鉴定热休克蛋白90(Hsp90)-辅助伴侣蛋白相互作用的抑制剂。
J Biomol Screen. 2009 Mar;14(3):273-81. doi: 10.1177/1087057108330114. Epub 2009 Feb 11.
4
Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone.一种苯并恶唑并氮杂环丁烷酮对蛋白激酶D功能的强效且选择性破坏作用
J Biol Chem. 2008 Nov 28;283(48):33516-26. doi: 10.1074/jbc.M805358200. Epub 2008 Sep 30.
5
Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B.基于对苯醌的抑制剂用于双特异性磷酸酶Cdc25B氧化还原调节的计算设计、合成及生物学评价
Org Biomol Chem. 2008 Sep 21;6(18):3256-63. doi: 10.1039/b806712k. Epub 2008 Jul 15.
6
A novel class of small molecule inhibitors of Hsp90.一类新型的热休克蛋白90(Hsp90)小分子抑制剂。
ACS Chem Biol. 2008 Oct 17;3(10):645-54. doi: 10.1021/cb800162x. Epub 2008 Sep 12.
7
Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents.开发一种384孔比色测定法,用于在还原剂存在下定量由化合物的氧化还原循环产生的过氧化氢。
Assay Drug Dev Technol. 2008 Aug;6(4):505-18. doi: 10.1089/adt.2008.151.
8
HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus.高通量筛选(HTS)鉴定出了西尼罗河病毒双组分NS2B-NS3蛋白酶的新型特异性非竞争性抑制剂。
Assay Drug Dev Technol. 2007 Dec;5(6):737-50. doi: 10.1089/adt.2007.101.
9
Development and implementation of a miniaturized high-throughput time-resolved fluorescence energy transfer assay to identify small molecule inhibitors of polo-like kinase 1.开发并实施一种小型化高通量时间分辨荧光能量转移分析方法,以鉴定polo样激酶1的小分子抑制剂。
Assay Drug Dev Technol. 2007 Dec;5(6):723-35. doi: 10.1089/adt.2007.102.
10
Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284).喹啉二酮Cdc25磷酸酶抑制剂DA3003-1(NSC 663284)的药理学及抗肿瘤活性
Anticancer Res. 2007 Sep-Oct;27(5A):3067-73.